In the gastritis mucosa of 28 patients with gastric cancer, non-synonymous low-abundance mutations in TP53 and ARID1A were detected in 11 cases (39.3%) and four cases (14.3%), respectively. This evidence concerns the gene ARID1A and gastric cancer.